ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,438,908 | -8.7% | 1,220,677 | +4.9% | 0.01% | 0.0% |
| Q2 2023 | $27,856,772 | +26.9% | 1,163,122 | -0.3% | 0.01% | +25.0% |
| Q1 2023 | $21,957,745 | +22.4% | 1,166,724 | +3.5% | 0.00% | 0.0% |
| Q4 2022 | $17,946,362 | -1.8% | 1,127,284 | +0.9% | 0.00% | 0.0% |
| Q3 2022 | $18,272,000 | +14.7% | 1,116,939 | -1.2% | 0.00% | +33.3% |
| Q2 2022 | $15,933,000 | -43.8% | 1,130,787 | -3.4% | 0.00% | -40.0% |
| Q1 2022 | $28,350,000 | -0.8% | 1,170,566 | -4.4% | 0.01% | 0.0% |
| Q4 2021 | $28,583,000 | +32.4% | 1,224,662 | -5.7% | 0.01% | +25.0% |
| Q3 2021 | $21,582,000 | -33.9% | 1,299,319 | -3.0% | 0.00% | -33.3% |
| Q2 2021 | $32,674,000 | +109.0% | 1,339,650 | +121.1% | 0.01% | +100.0% |
| Q1 2021 | $15,635,000 | -51.0% | 605,998 | +1.4% | 0.00% | -50.0% |
| Q4 2020 | $31,935,000 | +31.7% | 597,373 | +1.6% | 0.01% | +20.0% |
| Q3 2020 | $24,250,000 | -17.3% | 587,883 | -2.8% | 0.01% | -28.6% |
| Q2 2020 | $29,314,000 | -53.7% | 604,800 | -59.6% | 0.01% | -61.1% |
| Q1 2020 | $63,270,000 | +0.2% | 1,497,509 | +1.5% | 0.02% | +28.6% |
| Q4 2019 | $63,123,000 | +23.5% | 1,475,520 | +3.9% | 0.01% | +16.7% |
| Q3 2019 | $51,128,000 | +30.2% | 1,420,595 | -3.3% | 0.01% | +33.3% |
| Q2 2019 | $39,260,000 | -1.6% | 1,468,784 | -1.2% | 0.01% | -10.0% |
| Q1 2019 | $39,915,000 | +83.8% | 1,486,646 | +10.7% | 0.01% | +66.7% |
| Q4 2018 | $21,722,000 | -18.7% | 1,343,349 | +4.4% | 0.01% | -14.3% |
| Q3 2018 | $26,716,000 | +38.7% | 1,286,900 | +2.0% | 0.01% | +40.0% |
| Q2 2018 | $19,264,000 | +75.0% | 1,261,535 | +157.5% | 0.01% | +66.7% |
| Q1 2018 | $11,008,000 | -22.6% | 489,904 | +3.7% | 0.00% | -25.0% |
| Q4 2017 | $14,219,000 | -19.9% | 472,224 | +0.1% | 0.00% | -20.0% |
| Q3 2017 | $17,762,000 | +35.7% | 471,533 | +0.4% | 0.01% | +25.0% |
| Q2 2017 | $13,093,000 | -19.7% | 469,443 | -1.0% | 0.00% | -20.0% |
| Q1 2017 | $16,307,000 | +22.3% | 474,328 | +2.6% | 0.01% | +25.0% |
| Q4 2016 | $13,338,000 | -3.9% | 462,466 | +6.0% | 0.00% | 0.0% |
| Q3 2016 | $13,873,000 | +4.7% | 436,148 | +6.8% | 0.00% | 0.0% |
| Q2 2016 | $13,255,000 | -52.1% | 408,327 | -58.6% | 0.00% | -55.6% |
| Q1 2016 | $27,677,000 | -15.3% | 985,205 | +7.5% | 0.01% | -18.2% |
| Q4 2015 | $32,681,000 | +9.9% | 916,704 | +2.0% | 0.01% | +10.0% |
| Q3 2015 | $29,734,000 | -16.2% | 899,105 | +6.1% | 0.01% | -9.1% |
| Q2 2015 | $35,491,000 | +21.6% | 847,437 | -5.4% | 0.01% | +22.2% |
| Q1 2015 | $29,194,000 | +4.3% | 895,810 | +1.6% | 0.01% | +12.5% |
| Q4 2014 | $27,990,000 | +24.7% | 881,585 | -2.7% | 0.01% | +14.3% |
| Q3 2014 | $22,437,000 | +6.2% | 906,150 | -3.1% | 0.01% | 0.0% |
| Q2 2014 | $21,132,000 | -9.7% | 935,493 | -2.7% | 0.01% | 0.0% |
| Q1 2014 | $23,395,000 | -6.2% | 961,556 | -3.6% | 0.01% | -12.5% |
| Q4 2013 | $24,933,000 | -13.0% | 997,730 | -4.4% | 0.01% | -20.0% |
| Q3 2013 | $28,670,000 | +233.1% | 1,043,679 | +120.1% | 0.01% | +233.3% |
| Q2 2013 | $8,607,000 | – | 474,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |